What is NaoX Technologies?
Founded in 2018, NaoX Technologies specializes in the development and manufacturing of a diagnostic earpiece coupled with sophisticated software designed to enable on-the-go Electroencephalography (EEG) monitoring. This portable solution aims to revolutionize remote patient monitoring and diagnostics, offering a more accessible and convenient alternative to traditional EEG procedures. The company's focus on innovation in healthcare technology positions it as a key player in the burgeoning digital health market.
How much funding has NaoX Technologies raised?
NaoX Technologies has raised a total of $4.7M across 1 funding round:
Angel/Seed
$4.7M
Angel/Seed (2022): $4.7M with participation from Kurma Partners, Majycc e-Santé Invest, Bpifrance Investissement, and BNP Paribas Développement
Key Investors in NaoX Technologies
Kurma Partners
Kurma Partners is a prominent European investment firm focused on healthcare and biotechnology, supporting companies from pre-seed to growth stages. Their strategy emphasizes innovative projects from research institutions and venture capital financings in Biotech and MedTech, with a strong inclination towards novel drug development approaches.
Majycc e-Santé Invest
Majycc e-Santé Invest is an entity involved in the funding of e-health initiatives, likely focusing on digital health solutions and technologies that enhance healthcare delivery and patient outcomes.
BNP Paribas Développement
BNP Paribas Développement, a subsidiary of BNP Paribas, invests in SMEs and high-potential startups, particularly those with innovative technologies. They focus on supporting long-term development and sustainable growth, with investments typically ranging from 1 million to 20 million euros.
What's next for NaoX Technologies?
The substantial capital infusion, characterized as a major enterprise-level funding and strategic investment, signals a pivotal growth phase for NaoX Technologies. This backing is expected to accelerate product development, scale manufacturing capabilities, and expand market reach, particularly in the European and potentially global healthcare landscapes. The company is poised to leverage this financing to further refine its diagnostic earpiece and software, aiming to establish a dominant presence in the remote diagnostics and digital health sectors. Future strategic partnerships and further funding rounds may be anticipated as NaoX continues its trajectory.
See full NaoX Technologies company page
